These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 2580580)

  • 1. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding to thromboxane receptors on human platelets: correlation with biological activity.
    Armstrong RA; Jones RL; Wilson NH
    Br J Pharmacol; 1983 Aug; 79(4):953-64. PubMed ID: 6317122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
    Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
    Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of thromboxane receptors in human platelets.
    Jones RL; Wilson NH; Armstrong RA
    Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
    [No Abstract]   [Full Text] [Related]  

  • 7. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
    Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV
    Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
    Hanasaki K; Arita H
    Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha.
    Armstrong RA; Jones RL; Wilson NH
    Prostaglandins; 1985 Apr; 29(4):601-10. PubMed ID: 2988022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH; Gabriel D; Prior G; Schillinger E
    Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets.
    Fonlupt P; Croset M; Lagarde M
    Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
    Johnson GJ; Dunlop PC; Leis LA; From AH
    Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of platelet cyclic AMP level by thromboxane A2/prostaglandin H2 receptor agonists.
    Ishikawa Y; Ogawa A
    Thromb Res; 1991 Dec; 64(6):667-76. PubMed ID: 1665927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.